aprecia pharmaceuticals
3D Printing Webinar and Event Roundup: November 14, 2021
It’s a busy week ahead of webinars and industry events, and yes, there’s definitely more to do this week than just Formnext. In today’s 3D Printing Webinar and Event Roundup,…
3D Printing News Briefs: December 12, 2017
Today’s 3D Printing News Briefs features some of the latest happenings in medical, business, and education 3D printing news. Nanoscribe is celebrating its 10 year anniversary, while an industry expert…
The R&D Aspects of 3D Printing Pharmaceuticals
With the release of the first 3D printed and FDA approved drug last year, pharmaceutical companies from all around are investing in 3D printing technologies. It has proven to be…
Why Would We Think About 3D Printing Pharmaceuticals?
A few months ago coming home from a conference, the cardiac physician queued alongside me to board the flight back to the US was skeptical about the merits of 3D…
Study Shows High Accuracy of Medicinal 3D Printing
A study led by University of Cambridge Post-Doctoral Researcher Dr. Daniel Markl and Chemical Engineering professor Dr. Axel Zeitler demonstrated the viability of 3D printing technology in structuring and printing active…
3D Printing: The Stories We Missed This Week — July 9, 2016
Another week, another collection of important 3D printing news that we just didn’t have the chance to cover yet. With breaking news ranging from here on Earth to the orbit…
Aprecia’s 3D Printed Epilepsy Drug is Finally Commercially Available
Getting a new medication to the market is not a fast or easy process, no matter how promising the drug is. There’s the research and development phase, testing, more testing,…
3D Printing: The Stories We Didn’t Cover This Week–January 30
This week’s news covers internationally diverse stories representing 3D printing business news, as the industry seeks newer ways to accommodate the public’s growing interest in all things 3D printing related. It’s about…
The FDA Approves the First 3D Printed Pill to Help Prevent Epileptic Seizures
One of the largest hurdles that healthcare practitioners treating epilepsy need to overcome is often with their own patients. It turns out that an estimated 30 to 50 percent of…
Aprecia’s 3D Printed ZipDose Tablets Earn FDA Approval
You may recall that only weeks ago, we covered Aprecia Pharmaceuticals’ promising new easy to swallow quick dissolving ZipDose tablets. The pioneering 3D printed tablets combine the ease of consumption associated…
